The Office of the National Coordinator for Health Information Technology's ability to test new standards and policies is hindered without $5 million Obama requested for FY2016.
Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.
Precision medicine is still years away, if it's achievable at all, according to Technology Review.
The company is targeting the new product at researchers who need a comprehensive, pan-ethnic, and affordable solution to genotype many samples.
In an op-ed, President Barack Obama says the US is investing in precision medicine.
With NIH funds, organizations will build the 1 million volunteer cohort, while FDA's draft guidances will inform regulation of genetic tests critical for precision medicine.
Drug developers and genetic testing firms are contemplating how best to share variant classification data while protecting their commercial interests.
The proposed bill would provide the agency with a $2 billion budget increase for the second year in a row after more than a decade of stagnant funding.
Within the consortium community healthcare systems can contribute and access each other's data on cancer patients' molecular profiles and treatment outcomes.
The agency said it would disperse the funds to the clinic over the course of five years to collect, store, and distribute biospecimens for precision medicine research.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.